ORGANOIDSCIENCES
🇰🇷XKOS.476040South KoreaHealthcare
Price₩6,770.00+140.00 (+2.11%)
Latest anomalies
Neutral 0 detected in the last 120 days
- High: 2
- Medium: 0
- Low: 0
Debt to equity: rose sharply against the prior quarter
Working capital turnover: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Healthcare
- Biotechnology
- South Korea
Identity
- Exchange
- KOSDAQ . XKOS
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 76
- Headquarters
- Seongnam-si, South Korea
- Website
- https://organoidrx.com
Market
- Shares outstanding
- 6.6M
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- Not reported
- Gross margin
- Not reported
- Free cash flow
- Not reported
Latest news
News is not sourced for this exchange.
Business summary
ORGANOIDSCIENCES is a company in the healthcare sector, listed on KOSDAQ (South Korea) under the ticker 476040. Across the 240 trading sessions to the shares traded between ₩6,070.00 and ₩48,500.00, and the last close of ₩6,770.00 sits 2% of the way up that range. The company is headquartered in Seongnam-si, South Korea, and employs about 76 people.
Organoidsciences Ltd. develops regenerative therapies in South Korea. It develops ATORM, an adult tissue derived organoid based regenerative medicine platform for the treatment of intractable intestinal ulcers, as well as salivary glands, liver, and uterus disease areas; ODISEI solutions, an organoid-based discovery platform for screening evaluation and identification; and EXPANSION, an organoid-based advanced science for innovative solutions. The company was founded in 2018 and is based in Seongnam-si, South Korea.